Abstract
The Cambridge Health Institute’s sixth annual conference on microRNAs integrated exceedingly diverse academic and commercial interests. Included were novel technologies for microRNA profiling and nucleic acid sequencing, drug delivery technologies using gene therapy, and promising diagnoses and treatments for various diseases, especially types of cancer. The conference format comprised 42 presentations, each 25 min in length. This article gives telegraphic descriptions of ten of the presentations, to illustrate the range of conference topics. At least two other mutually nonintersecting choices of ten could have been used with equal effect.
Financial & competing interests disclosure
The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.